Search results
FDA Delays Decision on Moderna RSV Shot by 3 Weeks
Barrons.com· 6 days agoThe agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or...
Moderna to Present at Upcoming Conferences in May/June 2024
The Sacramento Bee· 3 days agoModerna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Moderna, Inc. (NASDAQ:MRNA) Director Noubar Afeyan Sells 15,000 Shares
ETF DAILY NEWS· 3 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) Director Noubar Afeyan sold 15,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 8th. Following ...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 1 day agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
Trending: Moderna's Proposed RSV Vaccine Faces Delayed FDA Review
Morningstar· 5 days ago13:53 ET -- Moderna is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. The company said that the U.S ...
Moderna’s Promise of mRNA Undercut by New RSV Vaccine
Bloomberg· 6 days agoConnecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation -...
EconoTimes· 7 days agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU...
FDA delays decision on Moderna's RSV shot until the end of May
FierceBiotech· 5 days agoModerna will have to consider that after receiving word that the FDA will not meet a May 12 decision...
Wealthspire Advisors LLC Has $301,000 Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 4 days agoWealthspire Advisors LLC trimmed its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 7.9% in the fourth quarter, according to its most recent disclosure with the Securities ...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters via AOL· 6 days ago(Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with...